Sesame Summit is back, learn more

blank

hema.to

hema.to is advancing precision immune medicine for millions of patients by bringing AI to blood measurements.

Visit website
25

Company size

Germany, Munich

Location

Website link

2020

Creation date

Company Description

Millions of patients with dangerous immune disease every year receive the wrong treatment, or are diagnosed poorly or too late. AI to accurately assess and target the immune system from blood test data is missing, which we are building using our cloud-based certified software that solves AI cytometry. This will deliver precision immune medicine for millions of patients and unlock a $20B+ revenue stream.

Follow hema.to

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.